IBA ends litigation over German proton therapy centre
BRUSSELS, June 4
BRUSSELS, June 4 (Reuters) - Belgian cancer therapy and diagnosis company Ion Beam Applications (IBA) said on Tuesday it had settled a legal dispute with the German buyer of a proton therapy centre.
IBA said in a statement that Westdeutsches Protonentherapiezentrum Essen GmbH (WPE) would buy the centre, which would be transferred in the coming weeks. IBA and WPE had also agreed an 18 year operation and maintenance agreement.
IBA took a write-down of 5.8 million euros ($7.6 million) in 2012, mostly related to the Essen project and restructuring expenses. ($1 = 0.7675 euros) (Reporting by Philip Blenkinsop)
- Cortege departs to take Mandela's body to lie in state |
- U.S. Mega Millions lottery up to $344 million, fourth biggest in its history
- Uruguay becomes first country to legalize marijuana trade
- UPDATE 1-U.S. Mega Millions lottery up to $344 million, fourth biggest in its history
- U.S. budget deal could usher in new era of cooperation